RGS4 Polymorphisms and Neurobiology of Schizophrenia

RGS4 多态性与精神分裂症的神经生物学

基本信息

项目摘要

DESCRIPTION (provided by applicant): This Research Career Development plan proposes a program of training and research designed to clarify the in vivo biological impact of variations in the gene encoding regulator of G-protein signaling subtype 4 (RGS4) polymorphisms in schizophrenia patients, individuals at risk for schizophrenia and matched healthy subjects. Demonstrating an association between genetic variations and intermediate phenotypes provides an important additional support for genetic association. RGS4 underexpression in the dorsolateral prefrontal cortex (DLPFC) of schizophrenia patients is reported. Subsequently, an association of RGS4 gene with schizophrenia has been reported in 7 independently ascertained populations in USA, Europe, india and Brazil. Our preliminary studies showed smaller DLPFC in schizophrenia patients homozygous for allele T of SNP4 and allele A of SNP18 but not in healthy subjects suggesting an interaction with other illness related variables. According to the neurodevelopmental hypothesis of schizophrenia pathogenic process starts prior to the emergence of clinical symptoms. Therefore, studying cerebral changes in persons at genetically high risk for developing schizophrenia who have not yet manifested the illness could minimize the confounds due to the illness. Smaller DLPFC was also observed in schizophrenia subjects homozygous for Val allele of the COMT gene that has also been associated with schizophrenia. The proposed study plans to utilize structural MRI and phosphorus magnetic resonance spectroscopy to characterize the differences in morphometry and membrane chemical (phosphomonoesters and phosphodiesters) concentrations associated with RGS4 variations in these study groups. We will explore the associations of these imaging measures with COMT polymorphisms. Characterizing intermediate phenotypes using "cross-longitudinal" design helps in delineating longitudinal trajectory of cerebral correlates of genetic polymorphisms, designing novel medications and early detection.
描述(由申请人提供):这项研究职业发展计划提出了一项培训和研究计划,旨在阐明精神分裂症患者、精神分裂症高危人群和匹配的健康受试者中G蛋白信号亚型4(RGS4)基因编码调节器的变异对体内生物学的影响。证明遗传变异和中间表型之间的关联为遗传关联提供了重要的额外支持。报道了RGS4在精神分裂症患者背外侧前额叶皮质(DLPFC)的低表达。随后,在美国、欧洲、印度和巴西的7个独立确定的人群中,RGS4基因与精神分裂症的关联被报道。我们的初步研究表明,精神分裂症患者的DLPFC较小,SNP4的等位基因T和SNP18的等位基因A纯合,但在健康受试者中不存在,提示与其他疾病相关变量存在交互作用。根据精神分裂症的神经发育假说,发病过程在临床症状出现之前就开始了。因此,研究尚未表现出精神分裂症的遗传高危人群的大脑变化可以将疾病造成的混乱降至最低。在COMT基因Val等位基因纯合的精神分裂症患者中也观察到较小的DLPFC,该基因也与精神分裂症有关。这项拟议的研究计划利用结构磁共振和磷磁共振光谱来表征这些研究组中与RGS4变异相关的形态计量和膜化学(磷单酯和磷二酯)浓度的差异。我们将探索这些成像方法与COMT基因多态之间的关系。使用“交叉纵向”设计描述中间表型有助于描绘大脑遗传多态相关者的纵向轨迹,设计新的药物和早期检测。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Konasale M Prasad其他文献

Konasale M Prasad的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Konasale M Prasad', 18)}}的其他基金

Neural Circuitry Resilience in Psychotic Disorders: A Multimodal Ultra-High Field Neuroimaging Study
精神障碍中的神经回路弹性:多模态超高场神经影像研究
  • 批准号:
    10467980
  • 财政年份:
    2021
  • 资助金额:
    $ 17.54万
  • 项目类别:
Neural Circuitry Resilience in Psychotic Disorders: A Multimodal Ultra-High Field Neuroimaging Study
精神障碍中的神经回路弹性:多模态超高场神经影像研究
  • 批准号:
    10013729
  • 财政年份:
    2021
  • 资助金额:
    $ 17.54万
  • 项目类别:
Synaptic Pruning and Complement Gene in Schizophrenia: Imaging & Cellular Studies
精神分裂症的突触修剪和补体基因:成像
  • 批准号:
    10415132
  • 财政年份:
    2018
  • 资助金额:
    $ 17.54万
  • 项目类别:
Synaptic Pruning and Complement Gene in Schizophrenia: Imaging & Cellular Studies
精神分裂症的突触修剪和补体基因:成像
  • 批准号:
    10161618
  • 财政年份:
    2018
  • 资助金额:
    $ 17.54万
  • 项目类别:
Neuroinflammation in Schizophrenia: An Integrated PET and High-Field Susceptibili
精神分裂症的神经炎症:综合 PET 和高场敏感性
  • 批准号:
    8768059
  • 财政年份:
    2014
  • 资助金额:
    $ 17.54万
  • 项目类别:
Neuroinflammation in Schizophrenia: An Integrated PET and High-Field Susceptibili
精神分裂症的神经炎症:综合 PET 和高场敏感性
  • 批准号:
    8925144
  • 财政年份:
    2014
  • 资助金额:
    $ 17.54万
  • 项目类别:
Environmental Factors in Cognition and Neurobiology of Early Onset Schizophrenia
早发性精神分裂症认知和神经生物学中的环境因素
  • 批准号:
    8411964
  • 财政年份:
    2012
  • 资助金额:
    $ 17.54万
  • 项目类别:
Neurobiology and Cognition in Early Onset Schizophrenia: Role of Environmental Fa
早发性精神分裂症的神经生物学和认知:环境 Fa 的作用
  • 批准号:
    8242207
  • 财政年份:
    2012
  • 资助金额:
    $ 17.54万
  • 项目类别:
RGS4 Polymorphisms and Neurobiology of Schizophrenia
RGS4 多态性与精神分裂症的神经生物学
  • 批准号:
    7474038
  • 财政年份:
    2005
  • 资助金额:
    $ 17.54万
  • 项目类别:
RGS4 Polymorphisms and Neurobiology of Schizophrenia
RGS4 多态性与精神分裂症的神经生物学
  • 批准号:
    7107958
  • 财政年份:
    2005
  • 资助金额:
    $ 17.54万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 17.54万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 17.54万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 17.54万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 17.54万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 17.54万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 17.54万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 17.54万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 17.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 17.54万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 17.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了